The Science Explained 1
A phase I/II clinical trial found that the most common side effects were mild and transient (Teichman et al., 2006): Injection site reactions (redness, mild swelling) Headaches Flushing or warmth Temporary water retention Joint tightness or tingling Transient fatigue or dizziness Serious adverse events are rare when the peptide is used under medical supervision at appropriate doses
PMID: 32849366 J Integr Med The use of melittin to enhance transgene expression mediated by recombinant adeno-associated virus serotype 2 vectors both in vitro and in vivo
Some users run five days on, two days off, treating it similarly to training schedules
Dietary Intake of Protein and Essential Amino Acids for Sustainable Muscle Development in Elite Male Athletes
Additionally, outcome measures were all provider graded, [and there were] no self-report measures, so it is difficult to understand the impact of treatment on symptoms, particularly from the patient perspective, she noted